Literature DB >> 22526536

Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.

Ilya D Ionov1, Nicholas N Severtsev.   

Abstract

RATIONALE: In rodents and dog, histamine induces catalepsy, a dopamine-dependent phenomenon that resembles the extrapyramidal signs of Parkinson's disease (PD). Histamine was also found to damage the dopaminergic neurons in rat substantia nigra. These facts, as well as an increase in brain histamine levels in Parkinsonian patients, suggest a pathogenic role for histamine in PD. As it seems, a comparison between pattern of experimental brain histamine toxicity and signs of PD would elucidate the role of histamine in PD pathogenesis.
OBJECTIVE: This study aimed to examine whether mouse histamine-induced catalepsy shares such age-related traits of PD as disease aggravation and underresponsiveness to 3,4-dihydroxy-L: -phenylalanine (L: -DOPA) in aged patients. For comparison purposes, haloperidol-induced catalepsy was studied.
METHODS: The intensity of catalepsy was measured as the time the mouse maintained an abnormal posture. The cataleptogens, histamine or haloperidol, were administered intracerebroventricularly and subcutaneously, respectively.
RESULTS: The cataleptogenic activity of histamine was significantly higher in 18-19-month-old and 22-23-month-old mice than 3-4-month-old ones. Aging was found to decrease the responsiveness of the histamine-induced catalepsy to L: -DOPA. The intensity of the haloperidol-induced catalepsy and its sensitivity to L: -DOPA were found independent of the animal's age.
CONCLUSIONS: The mouse histamine-induced catalepsy, unlike haloperidol-induced one, displays the same pattern of age dependency as PD. These findings support an involvement of histamine in the PD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526536     DOI: 10.1007/s00213-012-2706-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

Review 1.  Histaminergic transmission in the mammalian brain.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard; M Ruat
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

2.  Intraventricular infusion of the histamine H(1) receptor antagonist chlorpheniramine improves maze performance and has anxiolytic-like effects in aged hybrid Fischer 344xBrown Norway rats.

Authors:  R U Hasenöhrl; K Weth; J P Huston
Journal:  Exp Brain Res       Date:  1999-10       Impact factor: 1.972

3.  The central action of histamine. I. The effect of intraventricular histamine on the rat behavior.

Authors:  E Jagiello-Wójtowicz
Journal:  Pol J Pharmacol Pharm       Date:  1973 Nov-Dec

4.  Effects of antidepressants and antihistaminics on catalepsy induced by intracerebroventricular administration of histamine in mice.

Authors:  K Onodera
Journal:  Methods Find Exp Clin Pharmacol       Date:  1991 Jul-Aug

5.  Reversal of DOPA-induced arousal in reserpine-treated rabbits and mice by histidine.

Authors:  Y Z Abou; I B Farjo
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

6.  L-DOPA reverses motor deficits associated with normal aging in mice.

Authors:  Erika Allen; Kirsten M Carlson; Michael J Zigmond; Jane E Cavanaugh
Journal:  Neurosci Lett       Date:  2010-11-25       Impact factor: 3.046

7.  Effect of L-DOPA on endogenous histamine metabolism.

Authors:  N S Sharpless; M D Muenter; G M Tyce
Journal:  Med Biol       Date:  1975-04

8.  Studies on aging processes.

Authors:  L F Agnati; K Fuxe; F Benfenati; G Toffano; M Cimino; N Battistini; L Calza; E Merlo Pich
Journal:  Acta Physiol Scand Suppl       Date:  1984

9.  Characteristics of dopaminergic neurons in the aged male rat.

Authors:  K T Demarest; G D Riegle; K E Moore
Journal:  Neuroendocrinology       Date:  1980-09       Impact factor: 4.914

10.  Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.

Authors:  J O Rinne; O V Anichtchik; K S Eriksson; J Kaslin; L Tuomisto; H Kalimo; M Röyttä; P Panula
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

View more
  5 in total

1.  The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon.

Authors:  Thelma R Cowley; Rodrigo Esteban González-Reyes; Jill C Richardson; David Virley; Neil Upton; Marina A Lynch
Journal:  Neurochem Res       Date:  2012-09-26       Impact factor: 3.996

2.  Editorial Expression of Concern: Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.

Authors:  Ilya D Ionov; Nicholas N Severtsev
Journal:  Psychopharmacology (Berl)       Date:  2022-08       Impact factor: 4.415

3.  Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Cole Tolledo; Marlaina R Stocco; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-03-18       Impact factor: 5.590

4.  Effects of Immediate Aversive Stimulation on Haloperidol-Induced Catalepsy in Rats.

Authors:  Isabelle Waku; Adriano E Reimer; Amanda R de Oliveira
Journal:  Front Behav Neurosci       Date:  2022-04-11       Impact factor: 3.617

5.  Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia Activation.

Authors:  Gilly Wolf; Amit Lotan; Tzuri Lifschytz; Hagar Ben-Ari; Tirzah Kreisel Merzel; Pavel Tatarskyy; Michael Valitzky; Ben Mernick; Elad Avidan; Nickolay Koroukhov; Bernard Lerer
Journal:  Front Aging Neurosci       Date:  2017-06-16       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.